1.Chip analysis in exploring the pathogenesis of patients with ankylosing spondylitis
Xueting WEI ; Chaoyang LONG ; Fengzhen LI ; Zonghao WU ; Riyan ZHUGE ; Yanyun LI ; Zujie QIN
Chinese Journal of Rheumatology 2024;28(6):386-391
Objective:To explore the gene microarray of patients with ankylosing spondylitis in GEO database by using various bioinformatics methods, and to explore the possible targets and mechanisms of action.Methods:The GEO database was searched with "ankylosing spondylitis" the keyword, and the expression profile of genes related to AS was selected as the research object. Standard difference analysis, weighted co-expression analysis and gene set enrichment analysis were conducted to construct the disease set. GO and KEGG enrichment analysis were performed on the disease sets. The NCC algorithm identifies the first five key genes. THP-1 cells were implanted into RPMI-1640 culture medium containing 10% fetal bovine serum to multiply and construct the cell model of AS in vitro. The expression levels of 5 key genes were detected by qRT-PCR and Western blot. The experimental measurement data were expressed as mean± standard deviation, and the t test was used in comparison between the two groups. Results:One thousand six hundred and sixty seven disease genes were analyzed, functional annotation was mainly concentrated in 689 molecular components of cytoplasmic ribosomes, ribosomal subunits, ribosomes, cytoplasmic large ribosomal subunits, the structural composition of ribosomal REDOX enzyme activity, 1 002 molecular functions of NADH dehydrogenase activity, NADH dehydrogenase activity, and 5 764 molecular processes of mRNA catabolism and RNA catabolism The physical process involved 1 002 signaling pathways involved in Alzheimer′s disease, Prion disease, Parkinson′s disease, and the first 5 key genes were identified as RPS11, RPL4, RPL37A, RPS23, and RPS9. The experimental results were obtained by t test. The results showed that TNF-α mRNA ( t=5.59, P=0.001) and protein ( t=20.14, P<0.001) were significantly increased, indicating that LPS had induced inflammatory response in THP-1 cells, while RPL37AmRNA ( t=5.87, P=0.001), RPS11 mRNA ( t=3.88, P=0.008), RPS23 mRNA ( t=2.64, P=0.038), RPL37A protein ( t=3.18, P=0.030), RPS11 protein ( t=11.26, P<0.001), RPS23 protein ( t=5.64, P<0.001), increased, while RPS9 mRNA ( t=3.16, P=0.020), RPL4 mRNA ( t=2.54, P=0.044), RPS9 protein ( t=5.85, P<0.001) and RPL4 ( t=2.93, P=0.040) protein expressions decreased. RPL23 stimulated the joint synovial tissue to produce effect-T lymphocytes and release a large number of IL-2 and other inflammatory cytokines. RPS9 acts on the early stages of ribosomogenesis, and knocking down RPS9 reduced overall protein synthesis. RPL4 interacted with TTC22 protein to enhance the binding of WTAP mRNA to RPL4, which was associated with immune diseases. The nucleoprotein OGFOD1 catalyzed the hydroxylation of RPS23 and participated in the inflammatory process. The chromosome conformation confirmed the single nucleotide polymorphism function of IL23R genomic locus in AS disease. Conclusion:Ribosomal protein may be an important target for exploring the mechanism of AS inflammation.
2.Meta Analysis of Integrated Traditional Chinese and Western Medicine in Treatment of Chronic Liver Failure
Deyuan QIN ; Faming SHU ; Dewen MAO ; Ying HUANG ; Zujie QIN
Chinese Journal of Experimental Traditional Medical Formulae 2023;29(24):163-168
ObjectiveTo systematically evaluate the efficacy and safety of integrated traditional Chinese and western medicine in the treatment of chronic liver failure(CLF). MethodSeveral databases was searched from the establishment date of these databases to January, 2023, including China National Knowledge Infrastructure(CNKI), WanFang Data Knowledge Service Platform(WanFang), China Biomedical Literature Database(CBM), VIP Chinese Science and Technology Journal Database(VIP), Cochrane Library, Embase and PubMed. The randomized controlled trial(RCT) conforming to the treatment of CLF with integrated traditional Chinese and western medicine were screened and included, the control group was treated with basic western medicine, and the test group was treated with traditional Chinese medicine on the basis of western medicine. Then, the Cochrane risk bias assessment tool was used to evaluate the quality of the included literature, and Meta analysis was performed by RevMan 5.3 software. ResultEleven literatures with a total of 1 110 patients were included, and Meta analysis showed that the integrated traditional Chinese and western medicine was better than western medicine alone in the treatment of patients with CLF in improving the overall effective rate[relative risk(RR)=1.36, 95% confidence interval(CI) (1.27, 1.46), P<0.000 01], reducing the mortality[RR=0.35, 95% CI(0.23, 0.53), P<0.000 01)], reducing alanine aminotransferase(ALT) level[mean difference(MD)=-38.73, 95% CI(-54.59, -22.87), P<0.000 01], reducing the aspartate aminotransferase(AST) level[MD=-58.16, 95% CI(-83.45, -32.79), P<0.000 01] and reducing the total bilirubin(TBil) level[MD=-69.21, 95% CI(-94.15, -30.53), P<0.000 01], promoting serum albumin(ALB) level[MD=3.24, 95% CI(0.82, 5.66), P=0.009] and prothrombin activity(PTA) level[MD=5.44, 95% CI(3.38, 7.50), P<0.000 01], and improving the traditional Chinese medicine(TCM) symptom score[MD=-4.28, 95% CI(-8.39, -0.17), P=0.04]. ConclusionThe treatment of CLF with integrated traditional Chinese and western medicine has good clinical efficacy and safety. However, due to the limitations of the quality and quantity of the included literature, the above conclusions still need to be verified by larger scale of high-quality RCT, which is worthy of further expansion of the study.
3.Simultaneous Determination of Gallic Acid ,Cinnamic Acid and Catechin in 3 Processed Products of Rheum officinale by RP- HPLC
Jiangcun WEI ; Zhen XIE ; Zhengteng YANG ; Jiabao MA ; Zujie QIN ; Chenglong WANG ; Dongmei HUANG ; Wenrun ZHU ; Shengbin CHEN ; Qian HAN
China Pharmacy 2019;30(22):3053-3056
OBJECTIVE: To establish a method for simultaneous determination of gallic acid, cinnamic acid and catechin in 3 processed products of Rheum officinale. METHODS: RP-HPLC method was established. The determination was performed on Thermo ScientificTM Hypersil GOLD Dim column with mobile phase consisted of methanol-0.1% phosphoric acid solution (gradient elution) at the flow rate of 1.0 mL/min. The detection wavelength was set at 278 nm, and the column temperature was 30 ℃. The sample size was 10 μL. RESULTS: The linear range of gallic acid, cinnamic acid and catechin were 0.126 2-1.262 0 μg(r=0.999 9), 0.036 2-0.362 0 μg(r=0.999 9) and 0.177 9-1.779 4 μg(r=0.999 8), respectively. Quantitative limits were 25.4, 28.2, 62.5 ng, and detection limits were 6.2, 3.6, 11.8 ng, respectively. RSDs of precision, stability, repeatability and durability tests were all less than 3%. The recoveries ranged from 94.64%-102.71%(RSD=2.74%, n=9), 95.35%-102.49%(RSD=2.44%, n=9), 93.56%-103.66%(RSD=3.27%, n=9). The determination results showed that the contents of gallic acid and cinnamic acid in prepared R. officinale were higher, and the order of both were prepared R. officinale>steamed R. officinale>raw R. officinale. The content of catechin in raw R. officinale was higher, and the order of it was raw R. officinale> steamed R. officinale>prepared R. officinale. CONCLUSIONS: The method is sensitive, reliable and reproducible. It can be used to determine the contents of gallic acid, cinnamic acid and catechins in 3 processed products of R. officinale simultaneously.